维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="JOGI M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Shear strength of geomembrane-soil interface under unsaturated conditions显示文摘	Sharma J S Jogi M B	2006	Geotextiles and Geomembranes2006，24，：	1
2	NO conversion by dielectric barrier discharge and TiO2 Catalyst: effect of Oxygen显示文摘	Jogi I Bichevin V Laan M	2009	Plasma Chemistry and Plasma Processing2009，3，29：	1
3	Effects of com- bined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes 显示文摘	Sathyanarayana P Jogi M Muthupillat R	2011	Obesity2011，19，12：	1
4	Exenatide decreases hepatic fibro-blast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomized controlled trial显示文摘	Samson SL Sathyanarayana P Jogi M		0，，：	1
5	Semi-specific Microbactefium phyllos- phaerae-based microbial sensor for biochemical oxygen demand measure ments in dais, wastewaler 显示文摘	Kibena E Raud M Jogi E	2013	Environmental Science Pollution Research2013，20，4：	1
6	Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial显示文摘	Samson SL Sathyanarayana P Jogi M	2011	Diabetologia2011，54，12：	1
7	NO conversion by dielectric barrier discharge and TiO2 Catalyst: effect of oxygen 显示文摘	Jogi Jogi I Bichevin V Loan M	2009	Plasma Chemistry and Plasma Processing2009，29，3：	1
8	Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes 显示文摘	SATHYANARAYANA P JOGI M MUTHUPILLAI R	2011	Obesity2011，19，12：	1
9	Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes显示文摘	Sathyanarayana P Jogi M Muthupillai R	2011	Obesity(Silver Spring)2011，19，12：	1
10	NO conversion by dielectric bar-tier discharge and TiO2 Catalyst : effect of Oxygen 显示文摘	Jogi I Bichevin V Laan M	2009	Plasma Chemistry and Plasma Processing2009，29，3：	1
11	Induction of ID2 expression by hypoxia - inducible factor - 1 :a role in dedifferentiation of hypoxic neuroblastoma cells 显示文摘	Lofstedt T Jogi A Sigvardsson M	2004	J Biol Chem2004，279，39：	1
12	Effects of com- bined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes 显示文摘	Sathyanarayana P Jogi M Muthupillai R	2011	Obesity ( Silver Spring)2011，19，12：	1
13	Viral RNA detection by RIG-I-like receptor显示文摘	Yoneyama M Onomoto K Jogi M	2015	Curt Opin Immunol2015，32，：	1
14	Heart failure diagnostics based on ventilation/perfusion single photon emission computed tomography pattern and quantitative perfusion gradients显示文摘	Jogi J Palmer J Jonson B Bajc M	2008	Nucl Med Commun2008，29，8：	1
15	Encephalomyocarditis virus disrupts stress granules, the critical platform for triggering antiviral innate immune responses显示文摘	Ng C S Jogi M Yoo J S	2013	J Virol2013，87，17：	1
16	Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liv- er disease in a mouse model of obesity and in a randomised controlled trial 显示文摘	Samson SL Sathyanarayana P Jogi M	2011	Diabetologia2011，54，12：	1
17	Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 dia- betes 显示文摘	Sathyanarayana P Jogi M Muthupillai R	2011	Obesity (Silver Spring)2011，19，12：	1
18	Cancer cell diffe- rentiation heterogeneity and aggressive behavior in solid tumors 显示文摘	JOGI A VAAPIL M JOHANSSON M	2012	Ups J ned Sci2012，117，2：	1
19	Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity显示文摘	Onomoto K Jogi M Yoo JS	2012	PLoS One2012，7，43：	1
20	Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial显示文摘	Samson SL Sathyanarayana P Jogi M	2011	Diabetologia2011，54，12：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示